Skip to main content

Entera Bio Ltd.

ENTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001638097

No open-market purchases or sales by Entera Bio Ltd. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $19.0M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Entera Bio Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Entera Bio Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Entera Bio Ltd.
NameTitleLast reported holdingLast filingFilings, past year
Rubin Steven DDirector34,117Aug 7, 20263
Malca YonatanDirector100,231Aug 7, 20262
Taitel HayaDirector119,269Aug 7, 20263
Ellis SeanDirector208,132Aug 7, 20264
Yaacov-Garbeli DanaChief Financial Officer171,441IndirectAug 7, 20262
Galitzer HillelChief Operating Officer163,566Aug 7, 20262
Burshtein GregoryChief of R&D189,033Aug 7, 20262
Toledano Miranda JayneChief Executive Officer847,135Aug 7, 20263
Germano Geno JDirector65,014Aug 7, 20263
Lieberman Gerald MDirector338,454Jan 2, 20261
Ostrov Gerald MDirector75,657Jan 2, 20261
Garceau RogerDirector–Jan 3, 20240
Mayron RonDirector7,000Jan 3, 20240
Santora Arthur C IIChief Medical Officer–Apr 25, 20230
Jamas SpirosChief Executive Officer10,000Jan 24, 20220
Schwartz PhillipPresident of R&D607,410Jan 24, 20220
Ratan RameshU.S.based CFO10,000Jan 24, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 11, 2026 (view filing)Mar 92 daysGermano Geno JDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+20.0K$1.30+$26.0K+100.0%40.0K after
Mar 9, 2026 (view filing)Mar 54 daysEllis SeanDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+10.0K$1.23+$12.3K+5.6%188.1K after
Feb 17, 2026 (view filing)Feb 125 daysRubin Steven DDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+5.00K$1.49+$7.45K+50.0%15.0K after
Feb 11, 2026 (view filing)Feb 101 dayTaitel HayaDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+7.50K$1.48+$11.1K–
Feb 11, 2026 (view filing)Feb 101 dayGermano Geno JDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+20.0K$1.49+$29.8K–
Feb 11, 2026 (view filing)Feb 92 daysRubin Steven DDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+10.0K$1.20+$12.0KNew position10.0K after
Feb 11, 2026 (view filing)Feb 92 daysEllis SeanDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+18.0K$1.24+$22.3K+11.2%178.1K after
Dec 30, 2025 (view filing)Dec 291 dayToledano Miranda JayneChief Executive OfficerPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+11.0K$1.81+$19.9K+2.6%426.6K after
Jan 16, 2024 (view filing)Jan 124 daysTaitel HayaDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+9.50K$0.99+$9.40K+37.1%35.1K after
Jan 11, 2024 (view filing)Jan 101 dayTaitel HayaDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+7.62K$0.77+$5.86K+42.3%25.6K after
Dec 27, 2023 (view filing)5:00 PM ETDec 225 daysLieberman Gerald MDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+24.0K$0.71+$17.0K+11.8%227.0K after
Dec 27, 2023 (view filing)5:00 PM ETDec 225 daysLieberman Gerald MDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+24.0K$0.125+$2.99K–24.0K afterDerivative
Dec 27, 2023 (view filing)8:27 AM ETDec 225 daysToledano Miranda JayneChief Executive OfficerPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+24.0K$0.71+$17.0K+27.6%110.8K after
Dec 27, 2023 (view filing)8:27 AM ETDec 225 daysToledano Miranda JayneChief Executive OfficerPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+24.0K$0.125+$2.99K–24.0K afterDerivative
Aug 24, 2023 (view filing)Aug 222 daysTaitel HayaDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+18.0K$0.62+$11.2KNew position18.0K after
Aug 23, 2023 (view filing)Aug 212 daysLieberman Gerald MDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+20.0K$0.59+$11.8K+10.3%214.2K after
Aug 22, 2023 (view filing)Aug 211 dayEllis SeanDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+40.0K$0.60+$24.0K+64.4%102.1K after
Apr 6, 2023 (view filing)Apr 42 daysToledano Miranda JayneChief Executive OfficerPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+30.0K$1.01+$30.3K+52.8%86.8K after
Nov 15, 2022 (view filing)Nov 11-144 daysYaacov-Garbeli DanaChief Financial OfficerPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+56.6K$0.5294+$30.0KNew position56.6K after2 lots
Nov 15, 2022 (view filing)Nov 141 dayLieberman Gerald MDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+34.0K$0.57+$19.4K+21.2%194.2K after
Nov 15, 2022 (view filing)Nov 141 dayLieberman Gerald MDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+16.0K$0.5675+$9.08KNew position6.20K after4 lots
Nov 14, 2022 (view filing)Nov 113 daysEllis SeanDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+30.0K$0.53+$15.9K+93.5%62.1K after
Nov 14, 2022 (view filing)Nov 113 daysToledano Miranda JayneChief Executive OfficerPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+50.0K$0.53+$26.5K+735.3%56.8K after
Jul 25, 2022 (view filing)Jul 214 daysEllis SeanDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+14.9K$1.64+$24.4K+86.6%32.1K after
Jul 25, 2022 (view filing)Jul 214 daysLieberman Gerald MDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+19.5K$1.68+$32.7K+13.9%160.2K after
Jan 25, 2022 (view filing)Jan 1312 daysLateOstrov Gerald MDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+10.0K$2.74+$27.4KNew position10.0K after
Jan 24, 2022 (view filing)Jan 195 daysLateRatan RameshU.S.based CFOPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+10.0K$2.44+$24.4KNew position10.0K after
Jan 24, 2022 (view filing)Jan 186 daysLateJamas SpirosChief Executive OfficerPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+10.0K$2.85+$28.5KNew position10.0K after
Jan 24, 2022 (view filing)Jan 204 daysSchwartz PhillipPresident of R&DPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+10.0K$2.53+$25.3K+1.7%607.4K after
Jan 24, 2022 (view filing)Jan 186 daysLateLieberman Gerald MDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+2.80K$2.80+$7.84KNew position2.20K after4 lots
Jan 19, 2022 (view filing)Jan 181 dayMayron RonDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+7.00K$2.80+$19.6KNew position7.00K after
Jan 19, 2022 (view filing)Jan 145 daysToledano Miranda JayneDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+6.80K$2.79+$19.0KNew position6.80K after
Jan 18, 2022 (view filing)Jan 135 daysMalca YonatanDirectorPPurchaseOrdinary Shares, par value NIS 0.0000769 per share+7.23K$2.74+$19.8KNew position7.23K after